Arabic Arabic English English French French German German
dark

Esker Therapeutics Appoints New Team Members and Board Director

Esker Therapeutics today announced the appointment of several new team members: Kimberly Lindstorm, Ph.D., as vice president, regulatory. Travis Remarchuk, Ph.D., as executive director, CMC. Zhengbin (Bing) Yao, Ph.D., as a member of the board of directors. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics

Next Post

Notice to the Annual General Meeting of Elekta AB (publ)

Related Posts
Total
0
Share